3.99
Precedente Chiudi:
$3.97
Aprire:
$3.95
Volume 24 ore:
983.00K
Relative Volume:
0.23
Capitalizzazione di mercato:
$1.45B
Reddito:
$2.59M
Utile/perdita netta:
$-137.89M
Rapporto P/E:
-4.9259
EPS:
-0.81
Flusso di cassa netto:
$-69.76M
1 W Prestazione:
+9.48%
1M Prestazione:
-7.97%
6M Prestazione:
+2.71%
1 anno Prestazione:
+163.91%
Ataibeckley Inc Stock (ATAI) Company Profile
Nome
Ataibeckley Inc
Settore
Industria
Telefono
49 89 2153 9035
Indirizzo
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Confronta ATAI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ATAI
Ataibeckley Inc
|
3.985 | 1.44B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.89 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.65 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
813.59 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.52 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Iniziato | Needham | Buy |
| 2025-07-29 | Iniziato | Oppenheimer | Outperform |
| 2024-11-18 | Reiterato | H.C. Wainwright | Buy |
| 2024-04-03 | Aggiornamento | Maxim Group | Hold → Buy |
| 2022-11-01 | Iniziato | Loop Capital | Buy |
| 2021-11-30 | Iniziato | Maxim Group | Buy |
| 2021-11-11 | Iniziato | ROTH Capital | Buy |
| 2021-10-18 | Iniziato | H.C. Wainwright | Buy |
| 2021-09-01 | Iniziato | Jefferies | Buy |
| 2021-07-13 | Iniziato | Berenberg | Buy |
| 2021-07-13 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-13 | Iniziato | Cantor Fitzgerald | Buy |
| 2021-07-13 | Iniziato | Citigroup | Buy |
| 2021-07-13 | Iniziato | Cowen | Outperform |
| 2021-07-13 | Iniziato | Credit Suisse | Outperform |
| 2021-07-13 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Ataibeckley Inc Borsa (ATAI) Ultime notizie
AtaiBeckley Inc. (ATAI) Stock Analysis: A Biotech Gem With Over 200% Upside Potential - DirectorsTalk Interviews
Psychedelic: Analyst initiates Atai Beckley with Buy rating - TipRanks
Assessing AtaiBeckley (ATAI) Valuation After Recent Share Price Pullback - simplywall.st
Small cap wrap: American Resources, C3 Metals, TNR Gold, AtaiBeckley... - Proactive Investors
AtaiBeckley seen as key beneficiary of Spravato’s strong growth: Jefferies - Proactive financial news
AtaiBeckley Weighs Late Stage Options After Milestones And US$300m Raise - simplywall.st
The Bull Case For AtaiBeckley (ATAI) Could Change Following Promising BPL-003 Phase 2b Depression Data - Yahoo Finance
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 - Finviz
Atai Beckley N.V. (ATAI) Achieves Significant Milestone on Pipeline Development and Corporate Foundation - Finviz
Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift - simplywall.st
Is AtaiBeckley (ATAI) Turning Psychedelic Trial Momentum Into a Durable Mental Health Moat? - simplywall.st
Interesting ATAI Call Options For March 20th - Nasdaq
Atai Beckley announces presentations at ACNP - TipRanks
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… - Proactive financial news
AtaiBeckley shares clinical and preclinical data at ACNP Annual Meeting - Proactive financial news
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation - Investing News Network
AtaiBeckley Inc. Showcases Breakthrough Findings on BPL-003 for Treatment-Resistant Depression at ACNP Annual Meeting - Quiver Quantitative
Single-dose nasal spray shows rapid effect in hard-to-treat depression - Stock Titan
A Look At AtaiBeckley (ATAI) Valuation After Phase 2b Progress And Delaware Redomiciliation - simplywall.st
Atai Beckley N.V. (ATAI) is a Buy on Mental Therapeutics Opportunities - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
AtaiBeckley Completes Redomiciliation to the United States - Investing News Network
New Strong Sell Stocks for Jan. 13 - The Globe and Mail
atai Life Sciences stock rating reiterated by Cantor Fitzgerald - Investing.com
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - Investing News Network
AtaiBeckley Added to the Nasdaq Biotechnology Index - Investing News Network
Is It Too Late To Reassess AtaiBeckley (ATAI) After A 150% One Year Rally? - simplywall.st
Is It Too Late To Consider AtaiBeckley (ATAI) After A 145% One-Year Surge? - Yahoo Finance
Atai Beckley CEO says entering 2026 with ‘meaningful momentum’ - The Globe and Mail
AtaiBeckley outlines 2026 mental health treatment pipeline milestones By Investing.com - Investing.com Nigeria
Optimism flows from pot to psychedelics: Atai Beckley, Supernus stocks rise after analyst flags positive tailwinds from Trump’s marijuana order - MSN
Small cap wrap: AtaiBeckley, MustGrow Biologics, Silver Range Resources... - Proactive Investors
Needham Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
AtaiBeckley outlines 2026 mental health treatment pipeline milestones - Investing.com
AtaiBeckley Inc Provides 2026 Outlook and Clinical Updates Ahead of J.P. Morgan Healthcare Conference - Quiver Quantitative
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference - The Manila Times
AtaiBeckley issues 2026 outlook, flags multiple clinical milestones - Proactive financial news
Redomiciliation And Deregistration Move Could Be A Game Changer For AtaiBeckley (ATAI) - simplywall.st
Free float of AtaiBeckley Inc. – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Earnings and Revenue – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Earnings and Revenue – LS:A41WEP - TradingView — Track All Markets
AtaiBeckley Inc. Income Statement – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Revenue Breakdown – LS:A41WEP - TradingView — Track All Markets
AtaiBeckley Inc. Cash Flow – FWB:B72 - TradingView — Track All Markets
Diluted net income available to common stockholders of AtaiBeckley Inc. – GETTEX:B72 - TradingView — Track All Markets
AtaiBeckley Inc. Financial Disclosures & Filings - TradingView — Track All Markets
AtaiBeckley Inc. Statistics – XETR:B72 - TradingView — Track All Markets
AtaiBeckley Inc. Balance Sheet – FWB:B72 - TradingView — Track All Markets
Total operating expenses of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
Cash per share of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
AtaiBeckley (ATAI) Valuation Check As US Redomiciliation Marks A New Phase - simplywall.st
Ataibeckley Inc Azioni (ATAI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):